CBD is not a narcotic, the European Commission confirmed at the same day that the United Nations decided to remove cannabis and cannabis resin from the list of most dangerous drugs.
Following the ruling of the Court of Justice of the European Union (CJEU), the European Commission decided that cannabidiol (CBD) will not be regulated as a drug and can be qualified as food.
European Industrial Hemp Association (EIHA) was among the first to get informed about the new Commission’s decision.
“As predicted, the ECJ ruling has had a positive effect on the Commission’s position. Now that CBD can be qualified as food, the EIHA Novel Food joint application is perfectly set up for achieving safety assessment and standards for our growing industry”, said Lorenza Romanese, EIHA’s Managing Director. “We also welcome the vote of the United Nations, which leads to a modern and sound scientific approach regarding cannabis in general“, he added.
The Commission confirmed the news at an on-line press briefing as bellow:
“On this CBD or cannabidiol case, we have to think about different applicants. We have also taken into account the recent decision of the European Court of Justice, and on that basis, the Commission has reviewed its preliminary assessment and concluded that cannabidiol should not be considered a drug within the meaning of the United Nation Conventions… This means that cannabidiol can indeed be qualified as food. Commission services are now contacting different applicants to let them know that we are resuming our verification of the validity of their application that they have introduced”.
CBD was included in the EU’s Novel Food Catalogue in January 2019. Since then, the EU has required extensive testing and authorization of CBD products from food safety authorities. In July, it stopped reviewing applications for the authorization after announcing the Commission’s preliminary view that CBD extracted from the flowering tops of the Cannabis sativa L. plant should be considered a narcotic.
After the decision of the highest European court, there’s no more doubt – CBD has no narcotic properties and can be marketed as food.
VK PREMIUM offers an enhanced palette of consulting services to facilitate medical cannabis investments in Greece, including strategy & planning, products portfolio as of current & future market trends, licensing, grants utilizing Investment Incentive Law, design & construction of the facility in accordance with EU GMP & GACP standards and distribution strategies to secure sales success in foreign markets.
Call us at : +30 2106835560, send email to : info[@]vkmedicalcannabis.com or fill the bellow form: